Arbuthnot Commercial ABL has supported Inspirit Capital’s acquisition of BillerudKorsnäs Beetham Limited, in a corporate carve-out of the UK-based medical paper manufacturing division from a large Swedish group, BillerudKorsnäs AB. 

Arbuthnot Commercial ABL has provided £15m to finance the day-one consideration and to provide additional working capital, the specialist asset-based lender said in a press release.  

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The total package includes a £7m invoice discounting line, a £4m revolving inventory facility and a £4m Recovery Loan Scheme (RLS) facility. In early 2021, Arbuthnot Commercial ABL provided growth funding for another Inspirit Capital portfolio company, Procam Take 2.

Based at a mill site in Cumbria that has been producing paper since 1788 and now employs 130 people, the business produces sterile barrier papers for the packaging of medical devices and grease barrier papers for the quick service food products market as well as other types of industrial applications. The paper mill in Beetham has a capacity of around 45,000 tonnes per year, and in 2020 it generated revenue in excess of £40m.

To reflect its independence and strategic focus on the healthcare space, the new company has been rebranded as ‘Pelta Medical Papers’, with the word Pelta being ancient Greek for a lightweight shield.

Will Stamp, a founding partner at Inspirit Capital, said: 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are very pleased to be investing in this exciting business, which demonstrates Inspirit’s capacity to undertake complex corporate carve-out transactions. With the new funding line from Arbuthnot Commercial Asset Based Lending and the rebrand completed, Pelta Medical Papers is ideally positioned to continue its expansion into the healthcare space, which we see as a robust sector and a long-term driver of growth.”

Andrew Rutherford, commercial director at Arbuthnot Commercial ABL, said: 

“This is another exciting investment from Inspirit Capital, supporting Will and the team with a mix of acquisition finance and working capital funding to facilitate this transaction has been a pleasure. With Inspirit’s support and with the additional headroom we have structured within this deal, Pelta Medical Papers now has the freedom and the opportunity to develop further in the medical sector and achieve its full potential as a successful independent business.”

Arbuthnot Commercial ABL hits £300m milestone